NEOS Investment Management’s Cymabay Therapeutics CBAY Stock Holding History

NEOS Investment Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,189	Closed	-$359K	–	580
2023 Q4	$359K	Buy	+15,189	New	+$271K	0.03%	344

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

NEOS Investment Management's CBAY Position: Q1 2024 in Review

NEOS Investment Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 15,189 shares — an estimated $359K sold.

NEOS Investment Management first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $359K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

NEOS Investment Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
NEOS Investment Management sold 15,189 Cymabay Therapeutics shares in Q1 2024, an estimated $359K.
NEOS Investment Management first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
NEOS Investment Management's Cymabay Therapeutics position peaked at $359K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on NEOS Investment Management's 13F filing for Q1 2024, filed 13 May 2024.